# Combined Antibody Screening for Celiac and Diabetes Evaluation

> **NCT04677699** · — · ENROLLING_BY_INVITATION · sponsor: **Pacific Northwest Research Institute** · enrollment: 64410 (estimated)

## Conditions studied

- Type 1 Diabetes
- Celiac Disease

## Interventions

- **DIAGNOSTIC_TEST:** Combined Risk Score

## Key facts

- **NCT ID:** NCT04677699
- **Lead sponsor:** Pacific Northwest Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2020-12
- **Primary completion:** 2022-12
- **Final completion:** 2026-06
- **Target enrollment:** 64410 (ESTIMATED)
- **Last updated:** 2020-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04677699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04677699, "Combined Antibody Screening for Celiac and Diabetes Evaluation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04677699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*